NDC 42023-295-01 - Daptomycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42023-295
- Requested NDC
- 42023-295-01
- Package NDCs from labels
- 42023-295-01, 42023-295-10
- Manufacturer
- Par Health USA, LLC | MAIA Pharmaceuticals, Inc. | Gland Pharma Limited
- Effective date
- 2025-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Daptomycin - Par Health USA, LLC | MAIA Pharmaceuticals, Inc. | Gland Pharma Limited | Par Health USA, LLC | MAIA Pharmaceuticals, Inc. | Gland Pharma Limited | 2025-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42023-295-01 | Daptomycin | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 | |
| 42023-295-10 | Daptomycin | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42023-295-01 | EA - Each | 42023-295 | 78997fb4-325a-48aa-8599-5899ecb69f97 | 1 | 2025-10-14 |
| 42023-295-10 | EA - Each | 42023-295 | 02fa3ce6-c3a6-42fa-acec-bfc13584a739 | 1 | 2025-10-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daptomycin | DAPTOMYCIN | Hikma Pharmaceuticals USA Inc. | 74176769-b22e-4e41-8c56-051e15ec5fea | 2025-12-18 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Hemorrhoid | AESCULUS HIPP, HAMAMELIS, ALOE, CALC PHOS, CARBO AN, CARBO VEG, LACHESIS, LYCOPODIUM, MURIATICUM AC, NITRICUM AC, NUX VOM, PAEONIA, RATANHIA, SEPIA, SULPHUR | Natural Creations, Inc | db1b3aef-ba92-417c-b6f6-58e950ed4214 | 2025-12-16 | Warnings | QTT17582CB |
| DAPTOMYCIN | DAPTOMYCIN | Meitheal Pharmaceuticals Inc. | 4f39cddc-1cb7-41d4-a657-07f7903ee24f | 2025-12-08 | Warnings, Adverse reactions | NWQ5N31VKK |
| daptomycin | DAPTOMYCIN | BE Pharmaceuticals Inc. | 4cdf4099-db58-43b8-9fbc-afd997ccfa4b | 2025-10-24 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| DAPTOMYCIN | DAPTOMYCIN | Accord Healthcare Inc. | 956b068f-5958-49eb-9c9f-3b6e324e77d2 | 2025-10-09 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Accord Healthcare, Inc. | f69e9306-ffac-41c9-b277-a6d784f2e341 | 2025-10-09 | Warnings, Adverse reactions | NWQ5N31VKK |
| DAPTOMYCIN | DAPTOMYCIN | Meitheal Pharmaceuticals Inc. | 7d50f20e-5e26-4cc0-ae45-830df5a46a42 | 2025-09-10 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| daptomycin | DAPTOMYCIN | Mylan Institutional LLC | b7737862-e783-4af3-9521-ae00ed7a42aa | 2025-09-08 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Biocon Pharma Inc. | 914d4040-eb29-cda5-75e9-95060aa4fe6d | 2025-08-29 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| daptomycin | DAPTOMYCIN | BE Pharmaceuticals Inc. | c305bc9f-8aeb-40de-8492-154929764daf | 2025-08-29 | Warnings, Adverse reactions | NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Par Health USA, LLC | c1d47001-5e0f-46a3-b220-53f46b4fd6ac | 2025-08-19 | Warnings, Adverse reactions | NDA217630 42023-295-01 42023-295-10 42023-295 42023029501 403920 f210e0b8-5a7e-4ba9-b4ab-ad86a4ec8bf4 c1d47001-5e0f-46a3-b220-53f46b4fd6ac NWQ5N31VKK |
| daptomycin | DAPTOMYCIN | Mylan Institutional LLC | 95909792-972b-4c0c-b2ce-2be4bed36cff | 2025-08-15 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Hikma Pharmaceuticals USA Inc. | 6aa6300a-f59b-4260-b021-8a02cfaeabb7 | 2025-07-30 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | MAIA Pharmaceuticals, Inc. | d87bd6b5-bf92-49c1-879b-dc2add3deae6 | 2025-07-16 | Warnings, Adverse reactions | NDA217630 403920 NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Dr.Reddy's Laboratories Inc., | 7e9a1b82-f2ba-b2a4-619c-bea7768263e1 | 2025-06-30 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Daptomycin | DAPTOMYCIN | Qilu Pharmaceutical Co., Ltd. | e32c7141-fbd9-47c8-bd1e-94b880b2c5a6 | 2025-06-16 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Bestmade Natural Products BM182 Pellets | GRAPHITES, HEPAR SULF, MERC SOL, MURIATIC ACID | Bestmade Natural Products | 3242e013-2952-2b56-e063-6294a90a1693 | 2025-04-08 | Warnings | QTT17582CB |
| daptomycin | DAPTOMYCIN | Sintetica US LLC | 0e55bfa7-7dbf-4fa1-8aee-eac3fe4e05e3 | 2025-02-07 | Warnings, Adverse reactions | 403920 NWQ5N31VKK |
| Bestmade Natural Products BM62 | AMMONIUM BENZOICUM, AURUM MUR, CALC ARS, CARDUUS MAR, CROTALUS HORRIDUS, MURIATIC ACID, NUX VOM, PHOSPHORUS, VIPERA | Bestmade Natural Products | 2ce99cb7-fe9e-5da2-e063-6294a90afc4e | 2025-01-30 | Warnings | QTT17582CB |
| D-114 | ALUMINUM METALLICUM, AILANTHUS, BAPTISIA TINCTORIA, FRAGARIA VESCA, YOSCYAMUS NIGER, MURIATICUM ACID | DNA Labs | f6f7d369-64ef-0ed9-e053-6294a90a40fa | 2025-01-13 | Warnings | QTT17582CB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.